Morgan Jones, MD, will use the award to inform the design of a pilot trial centered on breast cancer. Her specific interests are in triple-negative breast cancer, disparities in treatment outcomes, and tumor microenvironments.
LEXINGTON, Ky. (Aug. 7, 2024) – Despite the prevalence and toll of late-onset Alzheimer’s disease—the most common type, which begins after age 65— causes of the disease remain only partly understood. Is it genes? Lifestyle? Environment?
He is acting chair and professor in the Department of Biostatistics in the University of Kentucky College of Public Health and a member of the CCTS Biostatistics, Epidemiology and Research Design Core.